Dawn Kuszynski, PhD

Dawn Kuszynski, PhD, currently serves as the Head of In Vivo Operations at TSRL, Inc. Previously, Dawn conducted groundbreaking research in drug discovery and development at Michigan State University and held an internship in intellectual property commercialization at MSU Technologies. Dawn's research background includes creating mutations in the Cardiac Ryanodine Receptor at the University of Michigan. Dawn holds a Doctor of Philosophy in Pharmacology and Toxicology and Integrative Toxicology from Michigan State University and a degree in Cell and Molecular Biology from the University of Michigan.